Trials / Unknown
UnknownNCT03963479
Vitamin B6 and Magnesium- A Clinical Trial on ASD Patients
Vitamin B6 and Magnesium on Neurobehavioral Status of Autism Spectrum Disorder: A Randomized, Double-Blind, Placebo Controlled Study
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh · Academic / Other
- Sex
- All
- Age
- 2 Years – 12 Years
- Healthy volunteers
- Not accepted
Summary
To determine whether Vitamin B6 and Magnesium improve neurobehavioral status in terms of General observation, Cognitive working, Socialization, Communication and Sensory Dysfunction in patient with Autism Spectrum Disorder.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | Magnesium and Vitamin B6 | Magnesium and Vitamin B6 will be given to the enrolled patients for 3 months |
Timeline
- Start date
- 2019-01-01
- Primary completion
- 2019-07-31
- Completion
- 2019-07-31
- First posted
- 2019-05-24
- Last updated
- 2019-07-31
Locations
1 site across 1 country: Bangladesh
Source: ClinicalTrials.gov record NCT03963479. Inclusion in this directory is not an endorsement.